These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 38115146)

  • 1. Metastatic papillary thyroid carcinoma in pleural effusion: a case report and review of the literature.
    Abutalib MA; Shams A; Tamur S; Khalifa EA; Alnefaie GO; Hawsawi YM
    J Med Case Rep; 2023 Dec; 17(1):521. PubMed ID: 38115146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent papillary thyroid carcinoma with pleural metastasis diagnosed by effusion cytology: a report of cases with clinicopathologic correlation.
    Sakamoto RI; Sumida LC; Lum CA; Tauchi-Nishi PS
    Hawaii J Med Public Health; 2015 Feb; 74(2):51-6. PubMed ID: 25755913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of the repeated examination of BRAF V600E mutation status in diagnostics of papillary thyroid cancer.
    Beiša A; Beiša V; Stoškus M; Ostanevičiūtė E; Griškevičius L; Strupas K
    Endokrynol Pol; 2016; 67(1):35-40. PubMed ID: 26884113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Papillary thyroid carcinoma with extensive squamous dedifferentiation metastatic to the lung: BRAF mutational analysis as a useful tool to rule out tumor to tumor metastasis.
    Acosta AM; Pins MR
    Virchows Arch; 2016 Feb; 468(2):239-42. PubMed ID: 26521063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRAF genetic heterogeneity in papillary thyroid carcinoma and its metastasis.
    Walts AE; Pao A; Sacks W; Bose S
    Hum Pathol; 2014 May; 45(5):935-41. PubMed ID: 24746198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific immunohistochemical detection of the BRAF V600E mutation in primary and metastatic papillary thyroid carcinoma.
    Zhu X; Luo Y; Bai Q; Lu Y; Lu Y; Wu L; Zhou X
    Exp Mol Pathol; 2016 Feb; 100(1):236-41. PubMed ID: 26795218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of BRAF c.1799T > A (p.V600E) mutation using residual routine fine-needle aspiration specimens of papillary thyroid carcinoma.
    Zhao H; Zhang ZH; Zhou B; Xiao T; Pan QJ; Guo HQ
    Diagn Cytopathol; 2015 Oct; 43(10):786-90. PubMed ID: 26152656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uncommon BRAF mutations in the follicular variant of thyroid papillary carcinoma: New insights.
    Rossi ED; Martini M; Bizzarro T; Capodimonti S; Cenci T; Lombardi CP; Pontecorvi A; Fadda G; Larocca LM
    Cancer Cytopathol; 2015 Oct; 123(10):593-602. PubMed ID: 26230187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of BRAF V600E mutation as a potential marker for prognostic stratification of papillary thyroid carcinoma: a long-term follow-up study.
    Daliri M; Abbaszadegan MR; Bahar MM; Arabi A; Yadollahi M; Ghafari A; Taghehchian N; Zakavi SR
    Endocr Res; 2014; 39(4):189-93. PubMed ID: 24679337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role and relevance of BRAF mutations in risk stratifying patients of papillary thyroid cancers along with a review of literature.
    Krishnamurthy A; Ramshankar V; Murherkar K; Vidyarani S; Raghunandhan GC; Das A; Desai PB; Albert K
    Indian J Cancer; 2017; 54(1):372-378. PubMed ID: 29199726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRAF(V600E) mutation is not a positive predictor for distant metastasis in sporadic papillary thyroid carcinoma.
    Jing FJ; Liang J; Liang ZY; Meng C; Long W; Li XY; Lin YS
    Chin Med J (Engl); 2013 Aug; 126(16):3013-8. PubMed ID: 23981603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of fine needle aspiration BRAF(V600E) mutation analysis in papillary thyroid cancer: a systematic review and meta-analysis.
    Fnais N; Soobiah C; Al-Qahtani K; Hamid JS; Perrier L; Straus SE; Tricco AC
    Hum Pathol; 2015 Oct; 46(10):1443-54. PubMed ID: 26232865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRAF mutation analysis of fine-needle aspiration biopsies of papillary thyroid carcinoma: impact on diagnosis and prognosis.
    Colanta A; Lin O; Tafe L; Ghossein R; Nafa K; Mitchell T; Ladanyi M; Arcila M
    Acta Cytol; 2011; 55(6):563-9. PubMed ID: 22156467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The co-relation of BRAF V600E mutation and factors affecting occurrence and prognosis of papillary thyroid carcinoma].
    Wang J; Liu LT; Cui D; He L; Liu DG
    Zhonghua Bing Li Xue Za Zhi; 2019 Apr; 48(4):288-292. PubMed ID: 30955264
    [No Abstract]   [Full Text] [Related]  

  • 15. Prognostic prediction of BRAF(V600E) and its relationship with sodium iodide symporter in classic variant of papillary thyroid carcinomas.
    Gao WL; Wie LL; Chao YG; Wie L; Song TL
    Clin Lab; 2012; 58(9-10):919-26. PubMed ID: 23163107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [BRAF gene mutation in the natural history of papillary thyroid carcinoma: diagnostic and prognostic implications].
    Lopes JP; Fonseca E
    Acta Med Port; 2011 Dec; 24 Suppl 4():855-68. PubMed ID: 22863493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Japanese patients with papillary thyroid carcinoma, TERT promoter mutation is associated with poor prognosis, in contrast to BRAF
    Nasirden A; Saito T; Fukumura Y; Hara K; Akaike K; Kurisaki-Arakawa A; Asahina M; Yamashita A; Tomomasa R; Hayashi T; Arakawa A; Yao T
    Virchows Arch; 2016 Dec; 469(6):687-696. PubMed ID: 27718012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Papillary microcarcinoma of the thyroid: clinical characteristics and BRAF(V600E) mutational status of 977 cases.
    Zheng X; Wei S; Han Y; Li Y; Yu Y; Yun X; Ren X; Gao M
    Ann Surg Oncol; 2013 Jul; 20(7):2266-73. PubMed ID: 23370668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation among the BRAF gene mutation status, clinicopathological features of primary tumour, and lymph node metastasizing of papillary thyroid carcinoma.
    Lukas J; Drabek J; Dudesek B; Vazan P; Stranska J; Jancik S; Mackova M; Syrucek M; Lukas D; Duskova J; Dundr P; Hintnausova B; Jiskra J
    Exp Clin Endocrinol Diabetes; 2014 May; 122(5):268-72. PubMed ID: 24839220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Papillary thyroid carcinomas with cervical lymph node metastases can be stratified into clinically relevant prognostic categories using oncogenic BRAF, the number of nodal metastases, and extra-nodal extension.
    Ricarte-Filho J; Ganly I; Rivera M; Katabi N; Fu W; Shaha A; Tuttle RM; Fagin JA; Ghossein R
    Thyroid; 2012 Jun; 22(6):575-84. PubMed ID: 22471242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.